Joshua Cohen is the founder of Amylyx Pharmaceuticals. He leads the company's mission to advance therapies for conditions like ALS and other motor neuron.
Joshua Cohen is the Co-Founder and Co-CEO of Amylyx Pharmaceuticals, a biotechnology company focused on developing treatments for neurodegenerative diseases. He leads the company's mission to advance therapies for conditions like ALS and other motor neuron diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library